Literature DB >> 17120029

Mediastinal lymphangiomatosis coexisting with occult thymic carcinoma.

Jun-ichiro Ikeda1, Eiichi Morii, Yasuhiko Tomita, Binglin Zhang, Toshiteru Tokunaga, Masayoshi Inoue, Masato Minami, Meinoshin Okumura, Katsuyuki Aozasa.   

Abstract

Mediastinal lymphangiomatosis in a 70-year-old woman was diagnosed on a medical checkup. The tumor was resistant to sclerotherapy with OK432 or bleomycin. The patient continued on a downhill course and died approximately 3 years after the initial diagnosis. Autopsy revealed a large tumor mass occupying the anterior mediastinum and firmly adhered to the pericardium and the pleura. The tumor consisted of two intermingled lesions: dilated vessels lined with D2-40-positive lymphatic endothelium and CD5-positive atypical cell nests with focal keratinization. The former was diagnosed as lymphangiomatosis and the latter as thymic squamous cell carcinoma. Vascular endothelial growth factor (VEGF)-C, a growth factor for lymphatic endothelial cells, was expressed by the carcinoma, and VEGF-C receptor was expressed by the endothelium of lymphangiomatosis. These findings suggested that VEGF-C derived from the thymic carcinoma induced the lymphangiomatosis lesion in a paracrine manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17120029     DOI: 10.1007/s00428-006-0333-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  9 in total

Review 1.  Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome.

Authors:  J L Faul; G J Berry; T V Colby; S J Ruoss; M B Walter; G D Rosen; T A Raffin
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

Review 2.  Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

Authors:  Anne Marie Byrne; D J Bouchier-Hayes; J H Harmey
Journal:  J Cell Mol Med       Date:  2005 Oct-Dec       Impact factor: 5.310

3.  Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma.

Authors:  H Y Huang; C C Ho; P H Huang; S M Hsu
Journal:  Lab Invest       Date:  2001-12       Impact factor: 5.662

4.  Disseminated lymphangiomatosis presenting with massive chylothorax.

Authors:  O Konez; P K Vyas; M Goyal
Journal:  Pediatr Radiol       Date:  2000-01

5.  [Diffuse thoracic lymphangiomatosis: diagnosis and treatment].

Authors:  E J Bermejo Casero; R Mongil Poce; R Arrabal Sánchez; A Fernández de Rota Avecilla; A Benítez Doménech; J L Fernández Bermúdez
Journal:  Arch Bronconeumol       Date:  2004-12       Impact factor: 4.872

6.  Lymphangiomatosis. Histologic and immunohistochemical analysis of four cases.

Authors:  P Ramani; A Shah
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

7.  An adult case of lymphangiomatosis of the mediastinum, pulmonary interstitium and retroperitoneum complicated by chronic disseminated intravascular coagulation.

Authors:  K Takahashi; H Takahashi; K Maeda; S Homma; T Uekusa; T Dambara; S Kira
Journal:  Eur Respir J       Date:  1995-10       Impact factor: 16.671

Review 8.  Lymphangiogenesis and cancer metastasis.

Authors:  Steven A Stacker; Marc G Achen; Lotta Jussila; Megan E Baldwin; Kari Alitalo
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

9.  Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors.

Authors:  P Salven; A Lymboussaki; P Heikkilä; H Jääskela-Saari; B Enholm; K Aase; G von Euler; U Eriksson; K Alitalo; H Joensuu
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.